SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing massive trading volume and a significant surge as investors react to a de-risking FDA update for its ANKTIVA bladder cancer application, which importantly does not require new clinical trials. This news, coupled with recent international approvals and high short interest, has ignited widespread community discussion about a potential short and gamma squeeze. The intense momentum highlights a fervent belief in the drug's long-term potential as a cancer treatment, driving bullish sentiment against a backdrop of active short positions.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a significant licensing agreement with Pfizer for its Matrix-M adjuvant, a deal seen by many as crucial validation for its non-mRNA technology. This development is intensifying community discussions about the stock's high short interest and potential for a squeeze, alongside ongoing pressure from an activist investor for management to expedite further partnerships and unlock core asset value.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is surging after being awarded a prime position on the U.S. Missile Defense Agency's SHIELD contract, enabling it to compete for critical task orders under the "Golden Dome" strategy. The community views this as a transformative catalyst, positioning INOD as a key player in government AI data training and potentially unlocking substantial future revenue from defense and global sovereign AI initiatives.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to compelling positive Phase 1 data for its oral drug soquelitinib in atopic dermatitis, showcasing strong efficacy in treatment-resistant patients and a favorable safety profile. The community is buzzing about its "best-in-class" potential in a massive market and a possible short squeeze, with many anticipating significant upside or a partnership. Despite the early stage of development, the innovative mechanism is driving substantial investor conversation.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending due to heightened global market uncertainty, fueled by renewed tariff threats against European nations and the ongoing Greenland situation. The community is sharply divided, with some anticipating a familiar "buy the dip" opportunity for the tech-heavy index, while others fear a more sustained market correction if trade tensions further escalate.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk (TTD) is trending due to its persistent decline, consistently hitting multi-year lows despite a generally positive market, leading to widespread shareholder frustration and calls for management accountability. Community discussions are heavily focused on CEO Jeff Green's perceived inaction and competitive pressures from 'walled garden' advertising platforms like Amazon. Investors are now keenly awaiting upcoming earnings as a potential make-or-break catalyst for the stock's direction.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as regulatory developments create a mixed outlook: a Massachusetts judge issued a preliminary injunction against prediction market Kalshi, a move seen as highly favorable for traditional sportsbooks. This positive catalyst is juxtaposed with the NCAA's call for a federal halt on college sports betting, intensifying investor debate around regulatory impacts and the rising competition from alternative betting platforms. Community sentiment is also weighing recent analyst upgrades and an increased share buyback authorization, leading to notable stock volatility.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following multiple analyst upgrades, with new price targets extending to $65, and reports of a potential $151 billion US SHIELD defense contract. The community is actively discussing the upcoming earnings report, including its Mobileye subsidiary, anticipating a significant breakout above the $50 level driven by the company's strategic importance in domestic chip manufacturing and AI.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending amid discussions of its strengthened position in the AI data center sector, following its recent full ownership of a key Texas data center campus and a strategic co-development partnership. The community is actively debating a potential short squeeze and eagerly awaiting an anchor tenant announcement for its hyperscale project, underscoring its perceived resilience despite past challenges.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is experiencing significant momentum, driven by a recent product innovation award and confirmed ongoing work with Celestial AI, now part of Marvell. The community is highly engaged, actively discussing the company's patented Optical Interposer platform as a crucial solution for AI and data center optical interconnects, which many believe positions the stock for a substantial re-rating. Anticipation is building for further announcements and a potential short squeeze as the market increasingly recognizes its technological advantages and strategic partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BLMZ board have approved up to a 1-for-50 reverse split (yes, not long implemented a 1-for-10) and have executed definitive agreements pertaining to another PIPE ($3.22M). 
 
Alas, this is indeed dilution.

Shortonmychest

StockTwits Web

BloomZ Inc.

 board have approved up to a 1-for-50 reverse split (yes, not long implemented a 1-for-10) and have executed definitive agreements pertaining to another PIPE ($3.22M). 
 
Alas, this is indeed dilution.

Aspire Biopharma Holdings Inc

Dominic Miller

@Sa_Langt_Sa_Godt r they gonna appeal ? R they gonna go live again and start trading ? Is this RS old or new that your talkin about

StockTwits for iOS

 r they gonna appeal ? R they gonna go live again and start trading ? Is this RS old or new that your talkin about

GameSquare Holdings Inc

UTime Ltd

Zoracles

Erayak Power Solution Group Inc

Youxin Technology Ltd - Ordinary Shares - Class A

OSR Holdings Inc

Yueda Digital Holding

marcial h

@bankbanks they&#39;ve already appealed per a prior 6-k. 
 
The stock is live to trade already on Pink Sheets. 
 
New PIPE and R/S approved by the board yesterday, 18 December 2025.

 they've already appealed per a prior 6-k. 
 
The stock is live to trade already on Pink Sheets. 
 
New PIPE and R/S approved by the board yesterday, 18 December 2025.

@Sa_Langt_Sa_Godt when will they announce this ? And does this mean they will go live again to trade regular and not pink sheet with a new RS

 when will they announce this ? And does this mean they will go live again to trade regular and not pink sheet with a new RS

@bankbanks announce what, sorry? Check their latest SEC filings - they released a new 6-K today. 
 
The exact timing of the R/S is down to the board. 
 
An R/S has no relation to this moving (or not moving) back to Nasdaq from OTC. 
 
Realistically speaking, an appeal board would be more likely to uphold delisting based upon how horrific the 1-for-10 split went i.e. BLMZ remains on OTC.  
 
Requiring a $3.22M PIPE infers there aren&#39;t funds to buy back shares, let alone continue business as usual.  
 
I get there&#39;s an option to select bullish/bearish, but it would appear your sentiment is not well founded.

 announce what, sorry? Check their latest SEC filings - they released a new 6-K today. 
 
The exact timing of the R/S is down to the board. 
 
An R/S has no relation to this moving (or not moving) back to Nasdaq from OTC. 
 
Realistically speaking, an appeal board would be more likely to uphold delisting based upon how horrific the 1-for-10 split went i.e. BLMZ remains on OTC.  
 
Requiring a $3.22M PIPE infers there aren't funds to buy back shares, let alone continue business as usual.  
 
I get there's an option to select bullish/bearish, but it would appear your sentiment is not well founded.

@Sa_Langt_Sa_Godt I get what your saying, I’m just bit to informed on this stuff like u r but do u think they will be back on nasdaq or not

 I get what your saying, I’m just bit to informed on this stuff like u r but do u think they will be back on nasdaq or not

@bankbanks after today&#39;s news, no.  
 
If you can&#39;t currently trade, perhaps contact your broker or see if you can transfer your position to another broker that has a wider variety of markets.

 after today's news, no.  
 
If you can't currently trade, perhaps contact your broker or see if you can transfer your position to another broker that has a wider variety of markets.

@Sa_Langt_Sa_Godt If it doesn&#39;t return to the Nasdaq, it can&#39;t do a r/s

 If it doesn't return to the Nasdaq, it can't do a r/s

Signature Bank

Agape ATP Corp

javier g

@Eagles999 companies on OTC can still perform an R/S. I&#39;m not aware of any bespoke clause preventing BLMZ from doing so.

 companies on OTC can still perform an R/S. I'm not aware of any bespoke clause preventing BLMZ from doing so.